Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR sell zonthiii

Start price
€74.64
17.11.20 / 50%
Target price
€70.00
17.11.21
Performance (%)
2.10%
End price
€76.21
18.11.20
Summary
This prediction ended on 18.11.20 with a price of €76.21. The SELL prediction by zonthiii shows the price for BioNTech SE ADR slightly increased by 2.10% during the runtime of the prediction. zonthiii has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to zonthiii what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Low dividend yield expected
negative Cash Flow expected
Significant cyclical dependencies

Comments by zonthiii for this prediction

In the thread Biontech SE diskutieren
Prediction Sell
Perf. (%) 2.10%
Target price 7.000
Change
Ends at 17.11.21

Sell mit Kursziel 7,0

Prediction Sell
Perf. (%) 2.10%
Target price 70.000
Change
Ends at 17.11.21

Kursziel geändert auf 70,0

Stopped prediction by zonthiii for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€76.21
18.11.20
€90.00
18.11.21
274.75%
20.08.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€85.01
16.11.20
€85.00
16.11.21
-12.20%
17.11.20

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group